Member Info for ria20

Yes going blue....so is POW RNS OUT....expect traction and movement on both

Expecting a big rally and this should move towards 1.50+

Mms ready to lift this up...news out

Boom ....commencement of diamond drilling at Molopo Farms Started

Mms ready to lift this now....POW also ready to motor RNS Out...should be great afternoon

Volumes crossed 6.7 million buys doubling sells....profit taking done by some ....should start to rise and gain momentum after lunch ....great day so far and should have a better and new highs this afternoon

Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals, Inc. (Merged 2011)

Azur Pharma PLC (Merged 2011)

EUSA Pharma (Acq 2012)

Gentium SpA (Acq 2014)

Alizé Pharma II (Acq 2016)

Celator Pharmaceuticals (Acq 2016)

Cavion Inc. (Acq 2019)

GW Pharmaceuticals (Acq 2021)

Buy ratings to go out later today and tomorrow from the big guns

Risers and gaining momentum ready and primed for a great afternoon.

Very nice and great morning here expect this, RDEX and POW to really move

5 million now and buys outstripping sells ....fabulous morning and ready for the next wave up

Https://www.trinitydelta.org/companies/redx-pharma/

still very cheap according to Trinity Delta and i very much and others agree....this is just the beginning and along way to rise to 94.00 how many percent is that?

The first few hours have been spectacular.....wow.....you are desperate to get in

Erebus you need to go to specsavers....as its not dropping but up 38 percent

On deal to sell inhibitor program......lovely press release just gone out

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Redx Pharma shares soared 44% to 28.70 pence each in London on Wednesday morning.

The Macclesfield, England-based clinical-stage biotechnology company said it will receive USD10 million upfront, with a potential for up to USD870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales.

Jazz Pharmaceuticals and Redx will collaborate to advance candidates through IND-enabling studies; Jazz Pharmaceuticals will be responsible for all clinical development, regulatory, manufacturing and commercialisation activities.

Its not even spiked yet just the beginning and standard pull back in any great share that rises....yes buy on the dip as we are in for a beautiful day and fabulous afternoon....volumes tell it all and amazing deal and RNS Today

4.3 million....100 times more than daily average....wow...buys outstripping sells....could to see the first pull back now ....primed and ready for the next wave up very soon

Number 1 on the leaderboard .....market is now taking notice

3.4 million now that is nearly 80 times more than the daily average in the first 3 hours and 45 minutes trading.....massive volume.....buys majority and outstripping sells....fabulous morning......if we have 7.5 million day volume what will the share price be?

Welcome aboard Gordonbennett1